Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 3
1981 8
1982 8
1983 10
1984 8
1985 5
1986 6
1987 1
1988 2
1989 3
1991 2
1999 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "1-(tert-butylamino)-3-(fluoren-9-ylideneamino)oxypropan-2-ol"
Page 1
Adrenergic beta receptors are not uniformly distributed in the cerebellar cortex.
Sutin J, Minneman KP. Sutin J, et al. J Comp Neurol. 1985 Jun 22;236(4):547-54. doi: 10.1002/cne.902360410. J Comp Neurol. 1985. PMID: 2997307
In order to determine the subtype of beta receptors, adjacent sections were incubated with either 125ICYP and the beta 2-selective antagonist IPS-339, or 125ICYP and the beta 1-selective antagonist practolol. Patches were observed after each incubation procedure, in …
In order to determine the subtype of beta receptors, adjacent sections were incubated with either 125ICYP and the beta 2-selective antagonis …
Study of beta-adrenoceptors and beta-adrenergic responsiveness in cultured "preneoplastic-like" and neoplastic rat hepatocytes.
Cortinovis C, Mayer D, Bouscarel B, Paris H, Murat JC. Cortinovis C, et al. Gen Pharmacol. 1985;16(3):259-63. doi: 10.1016/0306-3623(85)90079-5. Gen Pharmacol. 1985. PMID: 2410325
The order of potency of beta-antagonists either to displace the bound radioligand or to counteract isoprenaline induced cyclic AMP accumulation (IPS-339 greater than propranolol much greater than atenolol) indicates that the adrenoceptors present on the C1I cells ar …
The order of potency of beta-antagonists either to displace the bound radioligand or to counteract isoprenaline induced cyclic AMP accumulat …
Beta-adrenergic receptor subtypes in iris-ciliary body of rabbits.
Schmitt CJ, Gross DM, Share NN. Schmitt CJ, et al. Graefes Arch Clin Exp Ophthalmol. 1984;221(4):167-70. doi: 10.1007/BF02134259. Graefes Arch Clin Exp Ophthalmol. 1984. PMID: 6142847
Similar radioligand displacement by beta-adrenoceptor antagonists was in the order of potency: alprenolol greater than or equal to bupranolol = oxprenolol = timolol = propranolol greater than ICI 118,551 = IPS 339 much greater than betaxolol greater than metoprolol. …
Similar radioligand displacement by beta-adrenoceptor antagonists was in the order of potency: alprenolol greater than or equal to bupranolo …
Failure to demonstrate decreased beta-adrenergic receptor concentration or decreased agonist efficacy in term or preterm human parturition.
Dattel BJ, Lam F, Roberts JM. Dattel BJ, et al. Am J Obstet Gynecol. 1986 Feb;154(2):450-6. doi: 10.1016/0002-9378(86)90689-7. Am J Obstet Gynecol. 1986. PMID: 2868665
Studies with a specific beta 2-antagonist, IPS 339, indicated that 72% of receptors present were of the beta 2-subtype. Quantitative studies of beta-receptor concentrations in myometrium from women at term indicated no change in receptor concentration during labor. …
Studies with a specific beta 2-antagonist, IPS 339, indicated that 72% of receptors present were of the beta 2-subtype. Quanti …
The adrenoceptor blocking properties of the new beta 2-selective antagonist, IPS 339 on tracheal smooth muscle and on slow contracting skeletal muscle.
Holmberg E, Jeppsson AB, Lamm CJ, Waldeck B. Holmberg E, et al. Acta Pharmacol Toxicol (Copenh). 1980 Feb;46(2):150-5. doi: 10.1111/j.1600-0773.1980.tb02435.x. Acta Pharmacol Toxicol (Copenh). 1980. PMID: 6102425
The beta-adrenoceptor blocking properties of IPS 339 and propranolol were studied on isolated preparations of trachea and of the slow-contracting soleus muscle from the guinea-pig. ...However, on the trachea the slope of the Schildplot for IPS 339 agai …
The beta-adrenoceptor blocking properties of IPS 339 and propranolol were studied on isolated preparations of trachea and of t …
Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.
Iwamura M, Ishimori T, Makino M, Yasuda K, Izumi A, Himori N. Iwamura M, et al. Jpn J Pharmacol. 1983 Feb;33(1):219-26. doi: 10.1254/jjp.33.219. Jpn J Pharmacol. 1983. PMID: 6135813 Free article.
Inhibitory actions on adenosine diphosphate (ADP)-induced platelet aggregation of atenolol, dl- and d-D-32, IPS-339, pindolol and propranolol were investigated in guinea pigs for the purpose of obtaining a clue about a possible mechanism for the disaggregatory pheno …
Inhibitory actions on adenosine diphosphate (ADP)-induced platelet aggregation of atenolol, dl- and d-D-32, IPS-339, pindolol …
Characterization of the beta-adrenergic receptor on the human platelet: a beta 2-subtype.
Klysner R, Andersen PH, Geisler A, Winther K. Klysner R, et al. Acta Pharmacol Toxicol (Copenh). 1984 Apr;54(4):265-9. doi: 10.1111/j.1600-0773.1984.tb01928.x. Acta Pharmacol Toxicol (Copenh). 1984. PMID: 6145292
Isoprenaline-stimulated activity was blocked by the non-selective beta-antagonists propranolol and alprenolol and by the beta 2-selective antagonist IPS 339 and prenalterol. Metoprolol, a beta 1-selective blocker, was without effect on the isoprenaline-stimulated ad …
Isoprenaline-stimulated activity was blocked by the non-selective beta-antagonists propranolol and alprenolol and by the beta 2-selective an …
Basic pharmacological properties of prenalterol.
Mattsson H, Hedberg A, Carlsson E. Mattsson H, et al. Acta Med Scand Suppl. 1982;659:9-37. doi: 10.1111/j.0954-6820.1982.tb00833.x. Acta Med Scand Suppl. 1982. PMID: 6127902 No abstract available.
Beta-adrenergic agonists reduce spontaneous motor activity through either beta 1 or beta 2 receptors.
Frances H, Renwart N, Danti S, Cash R, Raisman R, Simon P. Frances H, et al. Pharmacol Biochem Behav. 1987 Jan;26(1):11-5. doi: 10.1016/0091-3057(87)90525-9. Pharmacol Biochem Behav. 1987. PMID: 2882523
In mice, the clenbuterol-induced decrease in spontaneous motor activity was antagonized by IPS-339 (beta 2 antagonist) but not by betaxolol (beta 1 antagonist), whereas the isoproterenol-induced decrease in spontaneous motor activity was completely antagonized by be …
In mice, the clenbuterol-induced decrease in spontaneous motor activity was antagonized by IPS-339 (beta 2 antagonist) but not …
58 results